These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31810814)

  • 21. Incidence of cataract surgeries in people with and without Alzheimer's disease.
    Hokkinen K; Kaarniranta K; Jämsen E; Lampela P; Hartikainen S; Tolppanen AM
    Acta Ophthalmol; 2022 Feb; 100(1):68-73. PubMed ID: 33988311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
    Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
    Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
    Rajamaki B; Hartikainen S; Tolppanen AM
    BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
    Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin discontinuation in persons with and without Alzheimer's disease.
    Vu M; Kettunen R; Tolppanen AM; Hartikainen S; Taipale H
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1145-1153. PubMed ID: 35449421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.
    Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
    J Alzheimers Dis; 2019; 69(3):807-816. PubMed ID: 31127778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the Finnish Care Register for Social Welfare in a nationwide cohort of people with Alzheimer's disease.
    Hyttinen V; Selander K; Tolppanen AM; Väyrynen R; Mielikäinen L; Linnosmaa I; Hartikainen S
    Scand J Public Health; 2024 Mar; 52(2):136-144. PubMed ID: 36342333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of oral anticoagulant use among people with and without Alzheimer's disease.
    Ali Babar B; Vu M; Koponen M; Taipale H; Tanskanen A; Kettunen R; Tiihonen M; Hartikainen S; Tolppanen AM
    BMC Geriatr; 2022 May; 22(1):464. PubMed ID: 35643439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.
    Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur J Pain; 2017 Apr; 21(4):658-667. PubMed ID: 27862681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
    Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
    J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and characteristics of psychiatric morbidity treated in specialized health care in a nationwide cohort of people with newly diagnosed Alzheimer's disease.
    Alastalo A; Tolppanen AM; Nietola M; Haapea M; Miettunen J; Hartikainen S; Jääskeläinen E
    Acta Psychiatr Scand; 2022 May; 145(5):507-516. PubMed ID: 35266140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatic and Preventive Medication Use before and after Alzheimer's Disease Diagnosis: A 10-Year Matched Cohort Study.
    Liau SJ; Bell JS; Lalic S; Tolppanen AM; Hartikainen S
    J Am Med Dir Assoc; 2024 Jul; 25(7):105012. PubMed ID: 38702043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
    Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    J Alzheimers Dis; 2017; 56(1):119-128. PubMed ID: 27911327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.
    Taipale H; Vuorikari H; Tanskanen A; Koponen M; Tiihonen J; Kettunen R; Hartikainen S
    Drugs Aging; 2015 Nov; 32(11):937-45. PubMed ID: 26476844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.
    Kettunen R; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Koponen M
    Eur J Clin Pharmacol; 2019 Mar; 75(3):417-425. PubMed ID: 30413841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland.
    Bell JS; Lönnroos E; Koivisto AM; Lavikainen P; Laitinen ML; Soininen H; Hartikainen S
    J Alzheimers Dis; 2011; 26(2):231-7. PubMed ID: 21593561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.
    Puranen A; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):94-101. PubMed ID: 26924266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
    Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
    Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.
    Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
    Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.